GC Biopharma Corp. (KRX:006280)
South Korea · Delayed Price · Currency is KRW 164,900
-4,400 (-2.60%)
At close: Jan 30, 2026
GC Biopharma Market Cap
GC Biopharma has a market cap or net worth of 1.88 trillion as of January 30, 2026. Its market cap has decreased by -2.66% in one year.
Market Cap
1.88T
Enterprise Value
3.03T
Revenue
1.93T
Ranking
n/a
PE Ratio
33.41
Stock Price
164,900.00
Market Cap Chart
Since August 29, 1995, GC Biopharma's market cap has increased from 29.09B to 1.88T, an increase of 6,370.63%. That is a compound annual growth rate of 14.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 1.88T | 3.71% |
| Dec 30, 2025 | 1.81T | -11.42% |
| Dec 30, 2024 | 2.05T | 43.03% |
| Dec 28, 2023 | 1.43T | -3.09% |
| Dec 29, 2022 | 1.48T | -40.60% |
| Dec 30, 2021 | 2.49T | -46.31% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Celltrion Pharm | 3.24T |
| Hanall Biopharma | 2.62T |
| Daewoong Pharmaceutical | 1.96T |
| Ildong Pharmaceutical | 1.20T |
| Chong Kun Dang Pharmaceutical | 1.15T |
| Daewoong | 977.29B |
| DongKook Pharmaceutical | 840.19B |
| Boryung | 783.98B |